Trifarotene Cream for Acne (LEAP Trial)

"Candidates are sought to join this experiment, requiring they possess acne and stand between their teenage years and mid-thirties. A total of 120 participants will be accepted in the study."

"The eligibility requirements for this clinical trial stipulate that participants must be between 13 and 35 years old. There are 18 studies available to minors, while 27 trials cater towards those above the age of 65."

"Accurate data on Trifarotene Cream's safety is available, so it was rated a 3. This product has also been approved for use and is currently in Phase 4 clinical trials."

"The current study has 22 sites of operation, spanning from Evansville to Fountain Valley and San Diego. To reduce the amount of travel needed for participation, it is suggested that individuals look for a clinic in their vicinity."

"Currently, there is a pair of live studies evaluating the efficacy of Trifarotene Cream with no trials in Phase 3. 43 separate medical establishments are participating in these trials and most of them are located in Arlington, Texas."

"This medical trial is no longer accepting participants. It was posted on December 27th 2021, and the last update occured on July 28th 2022. If you are looking to join a different research study, there are 46 trials recruiting individuals with acne and 2 studies searching for volunteers to use Trifarotene Cream."

"This clinical trial is not currently enrolling patients; the initial post date was December 27th 2021 and it was last updated on July 28th 2022. However, there are 48 other studies that have open recruitment presently."

"The journey of Trifarotene Cream began in 2021, when it was first researched under the patronage of Galderma R&D. After a successful Phase 1 trial involving 118 participants, this cream ultimately achieved its drug approval status. Currently there are two active clinical trials for Trifarotene Cream that span 4 countries and 34 cities."